Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF

Creative Commons License

Verheugt F. W. A., Ambrosio G., Atar D., Bassand J., Camm A. J., Costabel J. P., ...More

AMERICAN JOURNAL OF MEDICINE, vol.132, no.12, pp.1431-1447, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 132 Issue: 12
  • Publication Date: 2019
  • Doi Number: 10.1016/j.amjmed.2019.06.008
  • Journal Name: AMERICAN JOURNAL OF MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1431-1447
  • Keywords: Anticoagulation, Antiplatelet therapy, Bleeding, Mortality, Stroke, ESC GUIDELINES, MYOCARDIAL-INFARCTION, ANTIPLATELET THERAPY, TRIPLE THERAPY, MANAGEMENT, ASPIRIN, RISK, WARFARIN, REGISTRY, STRATIFICATION
  • Dokuz Eylül University Affiliated: Yes

Abstract

BACKGROUND: Many patients with atrial fibrillation have concomitant coronary artery disease with or without acute coronary syndromes and are in need of additional antithrombotic therapy. There are few data on the long-term clinical outcome of atrial fibrillation patients with a history of acute coronary syndrome. This is a 2-year study of atrial fibrillation patients with or without a history of acute coronary syndromes.